Susan Melhorn

Senior Research Scientist

University of Washington
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Accumulated preclinical literature demonstrates that hypothalamic inflammation and gliosis are underlying causal components of diet-induced obesity in rodent models. This review summarizes and synthesizes available translational data to better understand the applicability of preclinical findings to human obesity and its comorbidities. The published literature in humans includes histopathologic analyses performed postmortem and in vivo neuroimaging studies measuring indirect markers of hypothalamic tissue microstructure. Both support the presence of hypothalamic inflammation and gliosis in children and adults with obesity. Findings predominantly point to tissue changes in the region of the arcuate nucleus of the hypothalamus, although findings of altered tissue characteristics in whole hypothalamus or other hypothalamic regions also emerged. Moreover, the severity of hypothalamic inflammation and gliosis has been related to comorbid conditions, including glucose intolerance, insulin resistance, type 2 diabetes, and low testosterone levels in men, independent of elevated body adiposity. Cross-sectional findings are augmented by a small number of prospective studies suggesting that a greater degree of hypothalamic inflammation and gliosis may predict adiposity gain and worsening insulin sensitivity in susceptible individuals. In conclusion, existing human studies corroborate a large preclinical literature demonstrating that hypothalamic neuroinflammatory responses play a role in obesity pathogenesis. Extensive or permanent hypothalamic tissue remodeling may negatively affect the function of neuroendocrine regulatory circuits and promote the development and maintenance of elevated body weight in obesity and/or comorbid endocrine disorders.

Year:

2022

Collaborators (10)

Charles DeCarli

Professor/Director of the UCD ADRC

University of California, Davis

UNITED STATES
View details

Mauricio Dorfman

Research Associate Professor

University of Washington

UNITED STATES
View details

Jenny Kanter

Research Associate Professor

University of Washington

UNITED STATES
View details

Suchitra Chandrasekaran

Associate Professor

Emory University

UNITED STATES
View details

Alexa Beiser

Boston University

UNITED STATES
View details

Jose M. Garcia

-

UNITED STATES
View details

Yumei Feng Earley

Professor

University of Rochester Medical Center

UNITED STATES
View details

Ellen A Schur

Professor of Medicine

University of Washington

UNITED STATES
View details

Sudha Seshadri

Director

University of Texas Health Science Center at San Antonio

UNITED STATES
View details

Ana Patricia Valencia

Research Assistant Professor

University of Washington

UNITED STATES
View details